InvestorsHub Logo
Followers 0
Posts 69
Boards Moderated 0
Alias Born 01/26/2006

Re: None

Thursday, 09/28/2006 7:13:15 AM

Thursday, September 28, 2006 7:13:15 AM

Post# of 6489
NEWS!! Diabetes Type I & Prostate cancer results!

WHAT A GREAT DAY!!

Diabetes:
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2265.2006.02600.x

Conclusions Seven days treatment with IGF-I/IGFBP-3 complex enhanced overnight insulin sensitivity and reduced GH levels, but there was no effect on glomerular hyperfiltration or albumin excretion rate

Prostate Cancer:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16983336&...
Together, these studies provide the first evidence that IGFBP-3 has direct, IGF-independent inhibitory effects on angiogenesis providing an additional mechanism by which it exerts its tumor suppressive effects and further supporting its development for clinical use in the therapy of patients with prostate cancer.

Dunger & Iplex involved in the Diabetes study and Shiry & Pinchas Cohen in the Prostate cancer study!

Both studies are not published yet!

CF.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News